Correction
- PMID: 38972704
- DOI: 10.1016/j.jaip.2024.06.007
Correction
Erratum for
-
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.J Allergy Clin Immunol Pract. 2024 May;12(5):1215-1224.e3. doi: 10.1016/j.jaip.2024.02.007. Epub 2024 Feb 14. J Allergy Clin Immunol Pract. 2024. PMID: 38360213 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources